Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Entire DC Network
Factors Influencing Resilience Among Haematological Cancer Survivors, Katherine S. Gallager
Factors Influencing Resilience Among Haematological Cancer Survivors, Katherine S. Gallager
Theses: Doctorates and Masters
Haematological cancers in bone marrow (leukaemia) and the immune system (lymphomas or myeloma) represent the sixth most common adult tumour group in Australia. These cancers often develop without warning and require intensive treatment regimes that last on average eight months, but may continue for a lifetime depending on the diagnosis. Encouragingly, advancing cancer treatments, a key accomplishment of cancer research over the past 40 years, have resulted in a growing community of cancer survivors. Approximately two in three adults diagnosed with haematological cancer (HC) can now expect to survive more than five years. However, they must attempt to navigate the …
A Resiliency Perspective Of The Lived Experience Of Parenting Infants And Young Children With Cystic Fibrosis In The Context Of Early Lung Disease Surveillance, Cindy Branch-Smith
A Resiliency Perspective Of The Lived Experience Of Parenting Infants And Young Children With Cystic Fibrosis In The Context Of Early Lung Disease Surveillance, Cindy Branch-Smith
Theses: Doctorates and Masters
Scientific and technological advances over the past few decades have contributed to an exponential increase in life expectancy for infants born with cystic fibrosis (CF), which can cause fatal lung disease. There has been a paradigmatic shift from reactive treatment towards early disease detection and aggressive intervention of paediatric CF. Previous research has investigated parents’ experiences of the diagnosis phase and later life stages such as adolescence and transition to adulthood. Less is understood about the experience of parenting infants and young children with CF, and no research addresses this during early surveillance for CF lung disease. Early surveillance is …